Literature DB >> 11173587

Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.

Jamal Benfares1, Agnés Le Tourneau, Josée Audouin, György Szekeres.   

Abstract

Immunostaining of the cell cycle-associated Ki-67 antigen was studied, using the Ki-67-specific MIB-1 monoclonal antibody on slides prepared by cytocentrifugation of cultured A375 melanoma cells. Immunomorphological analysis of the Ki-67 immunostaining pattern of both nuclear and nucleolar locations was carried out following pre-treatment of the slides including ribonuclease and deoxyribonuclease pre-digestion of the cells. Immunostaining of nucleolar Ki-67 was reduced by ribonuclease pre-digestion, but was not altered by deoxyribonuclease pre-treatment. Ribonuclease did not reduce the staining intensity of Ki-67 in the nuclear matrix, but the intensity decreased after deoxyribonuclease pre-digestion. We suggest that the Ki-67 molecule may play an important role in ensuring contact between nuclear DNA and nucleolar RNA during transcriptional processes in cell proliferation.

Entities:  

Year:  1996        PMID: 11173587     DOI: 10.1007/bf02893952

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Which proliferation markers for routine immunohistology? A comparison of five antibodies.

Authors:  D S Rose; P H Maddox; D C Brown
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

3.  The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA.

Authors:  F Lopez; F Belloc; F Lacombe; P Dumain; J Reiffers; P Bernard; M R Boisseau
Journal:  Exp Cell Res       Date:  1994-02       Impact factor: 3.905

4.  Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1.

Authors:  D McCormick; H Chong; C Hobbs; C Datta; P A Hall
Journal:  Histopathology       Date:  1993-04       Impact factor: 5.087

5.  Comparison of 4 proliferation markers and their significance for evaluation of tumor dignity in intracranial tumors.

Authors:  C Hagel; P Schwartz; R Laas; D Stavrou
Journal:  Int J Oncol       Date:  1995-07       Impact factor: 5.650

Review 6.  Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer.

Authors:  C M Fenoglio-Preiser
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

Review 7.  Overview of the biologic markers of breast cancer.

Authors:  K Porter-Jordan; M E Lippman
Journal:  Hematol Oncol Clin North Am       Date:  1994-02       Impact factor: 3.722

8.  MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas.

Authors:  J A Ramsay; L From; N A Iscoe; H J Kahn
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

10.  Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens.

Authors:  J Diebold; K Dopfer; M Lai; U Löhrs
Journal:  Scand J Gastroenterol       Date:  1994-01       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.